Preparation of the Soluble Epoxide Inhibitor SWE101 and the DOCK1 inhibitor TBOPP

Preparation of the Soluble Epoxide Inhibitor SWE101 and the DOCK1 inhibitor TBOPP David A. Rogers and Kevin J. Frankowski https://doi.org/10.5281/zenodo.4637834 The National Institute on Aging has made a significant commitment to improving the treatment of Alzheimer’s disease through the funding of the TREAT-AD network (Target Enablement to Accelerate Therapy Development for AD, https://treatad.org/). One of Read More …

Welcome to IATSL – Who are We?

The Intelligent Assistive Technology and Systems Lab (IATSL) is  a multi-disciplinary group of researchers with backgrounds in engineering, computer science, occupational therapy, speech-language pathology, and gerontology. Our goal is to develop zero-effort technologies that are adaptive, flexible, and intelligent, to enable users to participate fully in their daily lives.  Our research primary focuses on older Read More …